2025 second_quarter Filing
RRFiled
June 30, 2025
Lobbying Activities (2)
FDA modernization policy issues; General issues related to rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases; Issues related to drug pricing; Issues related to reform of pharmacy benefit managers; Issues related to trade; Issues related to Newborn Screening and Genetic Testing;
Lobbyists (5)
VALERIE HENRY
Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
NewJOSEPH RACHINSKY jr
NewAISLING MCDONOUGH
Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
NewForeign Entities
KYOWA KIRIN CO., LTD
JP0Ownership: 100%